Keith Baker

Experience

• Chief Financial Officer

  Kineta • Current • Oct 2022 - Present

  Kineta (Nasdaq: KA) is a publicly-traded, clinical-stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Kineta has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the major challenges with current cancer therapy.

• CFO Consultant

  Baker CFO, LLC • Current • Feb 2016 - Present

  I provide ongoing CFO consulting services to businesses on a fractional, interim, or project basis.

• Additional experience 1
• Additional experience 2